Drug research

prednisone

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCNCT01995058	Exelixis	Phase 2	Terminated	2014-11Actual
KPL-301 for Subjects With Giant Cell ArteritisNCT03827018	Kiniksa Pharmaceuticals, Ltd.	Phase 2	Completed	2020-08-13Actual

ExelixisTerminatedPrimary completion: 2014-11 · Actual

Trial details

Kiniksa Pharmaceuticals, Ltd.CompletedPrimary completion: 2020-08-13 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.